Potential Efficacy of Polyphenols and Isothiocyanates in the Management of Genitourinary Diseases: A Systematic Review of Preclinical and Clinical Studies
Abstract
The global burden of genitourinary diseases is increasing worldwide, highlighting the need to identify new approaches for their prevention and treatment. In this context, polyphenols, isothiocyanates derived from plants of the Brassicaceae and Moringaceae botanical families, along with their natural sources, represent promising strategies, as they exhibit several health-promoting properties, including antioxidant, anti-inflammatory, and anti-fibrotic effects. However, a comprehensive overview of their benefits in the genitourinary system is currently unavailable. In this paper, we performed a systematic review of the literature by searching two scientific databases (MEDLINE and Scopus). A total of 27 preclinical studies and 16 clinical studies were included. Many studies have investigated the efficacy of isolated polyphenols in animal models of genitourinary diseases, as well as extracts or foods typically rich in polyphenols in humans, demonstrating potential benefits in the management of lithiasis, hyperoxaluria, prostatitis, benign prostatic hyperplasia, glomerulonephritis, vaginal dysbiosis, vaginosis, cystitis, and urinary tract infections. In contrast, few studies have examined isolated isothiocyanates, probably because their pharmacological role has only recently been recognized, and the results have been inconsistent. Further high-quality research is needed to confirm the preliminary evidence on polyphenols and to clarify the biological effects of isothiocyanates and…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.